These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 456334)
1. Neurophysiological and neurochemical studies on the action of the anticonvulsant gamma-hydroxy, gamma-ethyl, gamma-phenyl-butyramide. Tapia R; Drucker-Colín RR; Meza-Ruíz G; Durán L; Levi G Epilepsia; 1979 Apr; 20(2):135-45. PubMed ID: 456334 [TBL] [Abstract][Full Text] [Related]
2. Reversal of GABA-mediated inhibition of the electrically and potassium chloride evoked [3H]-GABA release from rat substantia nigra slices by DL-3-hydroxy-3-phenyl pentanamide. Meza-Toledo SE; Bowery NG Arzneimittelforschung; 2008; 58(2):53-61. PubMed ID: 18412018 [TBL] [Abstract][Full Text] [Related]
3. Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain. Concas A; Santoro G; Mascia MP; Maciocco E; Dazzi L; Ongini E; Biggio G J Pharmacol Exp Ther; 1993 Nov; 267(2):844-51. PubMed ID: 8246158 [TBL] [Abstract][Full Text] [Related]
4. Release of endogenous GABA from the substantia nigra is not controlled by GABA autoreceptors. Waldmeier PC; Wicki P; Feldtrauer JJ; Baumann PA Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):372-8. PubMed ID: 2555718 [TBL] [Abstract][Full Text] [Related]
5. Substantia nigra is an anticonvulsant site of action of topiramate in the focal pilocarpine model of limbic seizures. Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I Epilepsia; 2006 Sep; 47(9):1519-35. PubMed ID: 16981869 [TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant action of chlormethiazole is prevented by subconvulsive amounts of strychnine and aminophylline but not by bicuculline and picrotoxin. Pilip S; Urbańska EM; Swiader M; Włodarczyk D; Kleinrok Z; Czuczwar SJ; Turski WA Pol J Pharmacol; 2000; 52(4):267-73. PubMed ID: 11345482 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of GABA system involved in cyclosporine-induced convulsions. Shuto H; Kataoka Y; Fujisaki K; Nakao T; Sueyasu M; Miura I; Watanabe Y; Fujiwara M; Oishi R Life Sci; 1999; 65(9):879-87. PubMed ID: 10465348 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315 [TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant effect of intranigral fluoxetine. Pasini A; Tortorella A; Gale K Brain Res; 1992 Oct; 593(2):287-90. PubMed ID: 1450936 [TBL] [Abstract][Full Text] [Related]
10. Abortive amygdaloid kindled seizures following microinjection of gamma-vinyl-GABA in the vicinity of substantia nigra in rats. Le Gal La Salle G; Kaijima M; Feldblum S Neurosci Lett; 1983 Mar; 36(1):69-74. PubMed ID: 6856205 [TBL] [Abstract][Full Text] [Related]
11. gamma-Aminobutyric acid and glycine modulate each other's release through heterocarriers sited on the releasing axon terminals of rat CNS. Raiteri M; Bonanno G; Pende M J Neurochem; 1992 Oct; 59(4):1481-9. PubMed ID: 1402899 [TBL] [Abstract][Full Text] [Related]
12. Stimulated release of exogenous GABA and glutamate from cerebral cortical synaptosomes and brain slices by bis(acetato)tetrakis(imidazole) copper(II) complex. Abdul-Ghani AS; Abu-Hijleh AL; Qazzaz M; Muhaisen A; Ghani RA Biol Trace Elem Res; 2005; 108(1-3):205-14. PubMed ID: 16327073 [TBL] [Abstract][Full Text] [Related]
13. Neuropharmacology of amide derivatives of P-GABA. Habibuddin M; Pal M; Pal SP Indian J Exp Biol; 1992 Jul; 30(7):578-82. PubMed ID: 1459630 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of amino acid transmitter release from rat brain slices by phenytoin and related anticonvulsants. Skerritt JH; Johnston GA Clin Exp Pharmacol Physiol; 1983; 10(5):527-33. PubMed ID: 6139193 [TBL] [Abstract][Full Text] [Related]
15. Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy. Lücke A; Musshoff U; Köhling R; Osterfeld M; Mayer T; Wolf P; Schütte W; Speckmann EJ Br J Pharmacol; 1998 May; 124(2):370-6. PubMed ID: 9641555 [TBL] [Abstract][Full Text] [Related]
16. GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum. Starr MS Eur J Pharmacol; 1978 Apr; 48(3):325-8. PubMed ID: 639860 [TBL] [Abstract][Full Text] [Related]
17. Lack of proconvulsant action of GABA depletion in substantia nigra in several seizure models. Maggio R; Sohn E; Gale K Brain Res; 1991 Apr; 547(1):1-6. PubMed ID: 1650283 [TBL] [Abstract][Full Text] [Related]
19. Effect of convulsant and anticonvulsant agents on level and metabolism of gamma-aminobutyric acid in mouse brain. Löscher W; Frey HH Naunyn Schmiedebergs Arch Pharmacol; 1977 Feb; 296(3):263-9. PubMed ID: 840320 [TBL] [Abstract][Full Text] [Related]
20. Imaging the induction and spread of seizure activity in the isolated brain of the guinea pig: the roles of GABA and glutamate receptors. Federico P; MacVicar BA J Neurophysiol; 1996 Nov; 76(5):3471-92. PubMed ID: 8930287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]